Crv Ex-l Moonroof Leather None Smoker on 2040-cars

Auto blog

Acura NSX roadster finally on its way this year?

Autobild put together a slideshow forecasting various convertibles due to arrive from 2018 to 2023. The long-prophesied Acura NSX roadster graced the first slide, reportedly prepped for market launch later this year at a price of 200,000 euros. That's about 13,000 euros more spendy than the hardtop, a relative bargain. Don't call your Goldman private banker yet, though — that Autobild slide is likely as close as any of us will get to said roadster this year. We've been doing the hokey pokey with the droptop NSX for at least six years now. In 2012 an eager enthusiast corps thought a European patent might have revealed the convertible supercar, only to realize it was Acura protecting Tony Stark's screen gem in The Avengers (pictured). In 2016, Autocar reported that Honda viewed the NSX as a platform for experiment and tests of developing technology that "help [ Honda] understand where the brand is going." Those brand explorations meant Honda was "contemplating convertible, lightweight, non-hybrid and all-electric versions." In 2017, Internet snoopers happened on patent images for a droptop coupe first dubbed the "Baby NSX," then potentially the ZSX after more snooping dug up a trademarked name. Even though production plans for a "Small NSX" actually did exist, dated to before 2008, the Small NSX/BabyNSX/ZSX turned out to be the Honda Sports Vision GranTurismo entry when Honda couldn't make a business case for the genuine article. Here we are staring down the same wishing well. Last year Acura sold 137 NSXs in the U.S. through the end of Q1, and so far this year only 67 coupes found buyers in that time. We know the NSX is a halo car, but halos work to best effect when they're visible. So all we know now is that the talented hybrid would do well with any variant that would get it more visibility, of the top-down kind, the Type R kind, perhaps a road-legal, non-hybrid GT3 kind, or any other. Related Video:

Honda reports $1.9 billion profit in first quarter despite sales lag at home

Ford, General Motors and Chrysler have been living in a world of sunshine and buttercups after their April-through-June financials hit the newswire, and Toyota is doing pretty good as well. Honda? Not so much.
While Japan's third-largest manufacturer saw $1.9 billion in profits, the 5.1-percent jump was lower than expected thanks to a drop in its home-market sales. US sales also took a sting, as Honda hasn't been able to match the SUV and truck demand that are currently permeating the American market, despite an uptick in Accord sales.
Honda's initial forecasts targeted a take of 209.3 billion yen ($2.1 billion at today's rates), and while a $200 million shortfall is nothing to sniff at, we'd hardly take this as Honda being in trouble. And even with the dip, Honda hasn't adjusted its forecast for the fiscal year, which remains at 780 billion yen ($7.9 billion).

Honda Walking Assist Device begins US testing at Rehabilitation Institute of Chicago

For years, we've been wondering what implications Honda's Asimo robot could have in the real world, and now we're starting to get a sense of that. Honda announced that it will begin its first US clinical studies of the Walking Assist Device at the Rehabilitation Institute of Chicago in an effort to provided improved mobility for people who have suffered a stroke. While the automotive tie-in here is pretty weak, this is the first time we've heard about this device since it was unveiled back in 2008.
Weighing in at six pounds, Honda's device is fitted to the waist and legs of patients to make it easier to walk, and the 22.2-volt lithium-ion battery provides enough electricity for more than an hour of operation. According to Honda's press release, which is posted below, up to 80 percent of the almost 800,000 stroke victims each year (in the US alone) are afflicted with limited mobility, so a medical aid like this could have a big impact in the real world.